Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by skiboard09on Aug 14, 2020 10:49pm
158 Views
Post# 31411616

RE:RE:Is this something to worry about?

RE:RE:Is this something to worry about?

I feel bad for anyone who bought the last financing. Having to hold for 4 months now knowing we are doing less than 50 tests a day. 


How does Tripp justify his salary? He needs to go. Vote accordingly people. 


Also with almost 400 million shares o/s. I'm sure they will do the 8:1 roll back. Leaving us at 50 million shares. So they can keep doing raises to fund this thing. 


why put out big NRs and interviews stating that the initial order of 250k would bring us tens of millions in revenue and this would fund the company going forward. By the looks of it we are nowhere close. 


how can they ramp from 50 tests a day to 1000 ?  

Do they actually have the ability to do 1000?  


looking for answers Monday. 

 

Bullboard Posts